Stockreport

Precipio Provides Clarification To Amendment No.1 to Form S-1 Filing

Precipio, Inc.  (PRPO) 
US:NASDAQ Investor Relations: precipiodx.com/investors.html
PDF NEW HAVEN, Conn., Jan. 28, 2020 (GLOBE NEWSWIRE) -- The management team of Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), would like to provide an explan [Read more]